However, copy number gains of PTK2, the gene encoding FAK, has been shown to be a predictive marker for sensitivity to FAK inhibition in a breast cancer cell line, and PTK2 gene amplifications confer worse prognosis in patients with various cancer types [35]. The gene discussed is PTK2; the disease is breast cancer.